Testing a cream for grey hair
Part of Skin clinical trials.
This study tests a new cream that may help restore natural hair color. It is for people with grey hair who are otherwise healthy, and it explores a type of drug called an mTOR inhibitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 65 years old.
- You have grey hair (canities).
- You are generally healthy and able to follow the treatment instructions.
- You have not had a serious medical event (like a heart attack or stroke) in the last 90 days.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You have not used prescription creams or lotions on the treatment area in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment (CS-001) applied to the hair to see if it can reverse grey hair. It may help people who are bothered by grey hair and want to try a non-surgical option.
This trial tests if Chinese herbal treatments can reduce hair loss and reverse gray hair over 6 months. It may help adults who have thinning hair or graying, as long as they haven't dyed or permed their hair recently.
This study tests whether a cosmetic product can change the look of gray hair. It is looking for healthy adults with a moderate amount of natural gray hair.
This study tests two new topical treatments for hereditary hair loss. It may help you regrow hair or slow further thinning.
This trial tests a new cream for vitiligo on the face or neck. It aims to see if the cream can help bring color back to white patches.
This study tests a new drug (BG-A3004) for safety in healthy volunteers and people with certain skin conditions like alopecia areata, cutaneous lichen planus, or vitiligo. It helps find out if the drug is safe and how the body processes it.
Hear when a new Canities trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.